View Archive: 2013 |
2012 |
2011 |
2010 |
2009 |
2008 |
2007 |
2006 |
2005 |
2004 |
2003 |
2002 |
2001 |
2000 |
1999 |
1998June 18, 2013
Cytokinetics Announces Results From ATOMIC-AHF Will Be Presented At Late Breaking Clinical Trials Session At The European Society Of Cardiology Congress 2013
June 17, 2013
Cytokinetics Set to Join Russell Global Index
June 12, 2013
Amgen and Cytokinetics Announce Expansion of License for Omecamtiv Mecarbil
June 4, 2013
Cytokinetics Announces Publications Relating to Fast Skeletal Troponin Activation in Nemaline Myopathy
May 15, 2013
Cytokinetics to Hold Annual Meeting of Stockholders
April 30, 2013
Cytokinetics, Incorporated Reports First Quarter 2013 Financial Results
April 16, 2013
Cytokinetics to Announce First Quarter Results on April 30, 2013
April 4, 2013
Cytokinetics Announces Grant From Families with Spinal Muscular Atrophy for Preclinical Development of Tirasemtiv
April 1, 2013
Cytokinetics Announces Initiation of First-Time-in-Humans, Phase I Clinical Trial of CK-2127107
March 29, 2013
Cytokinetics to Present at Upcoming Healthcare Conferences
March 21, 2013
Cytokinetics Announces Presentation of Phase IIA Clinical Trial Data of Tirasemtiv in Patients with Myasthenia Gravis
March 18, 2013
Cytokinetics Announces Update to Heart Failure Program
March 13, 2013
Cytokinetics to Present Clinical Trial Data Relating to Tirasemtiv in Patients with Myasthenia Gravis
March 11, 2013
Cytokinetics to Present at 25th Annual Roth Conference
February 22, 2013
Cytokinetics to Present at Upcoming Healthcare Conferences
February 12, 2013
Cytokinetics Announces Opening of COSMIC-HF, A Phase II Clinical Trial of Oral Formulations of Omecamtiv Mecarbil in Patients with Heart Failure
February 8, 2013
Cytokinetics to Present at BIO CEO and Investor Conference
February 8, 2013
Cytokinetics Announces Changes to Its Board of Directors
February 5, 2013
Cytokinetics, Incorporated Reports Fourth Quarter 2012 Financial Results
January 29, 2013
Cytokinetics to Announce Fourth Quarter Results on February 5, 2013
January 25, 2013
Cytokinetics, Incorporated Receives NASDAQ Notice of Minimum Bid Price Compliance
